Neurofibromatosis Therapeutics Market Market : Global Industry Analysis and Opportunity Assessment, 2036

Future Market Insights

Neurofibromatosis Therapeutics Market

Key Insight

Neurofibromatosis type 1 (NF1) represents 60.7% of the disease type category, plexiform neurofibromas account for 37.1% of manifestation demand and hospitals hold 33.0% of end user sales in 2026. The neurofibromatosis therapeutics market was valued at USD 680.5 million in 2025 and is forecast to post an 8.4% CAGR between 2026 and 2036.

July 23, 2026

Anurag Sharma

250 Pages

Cite this Report

Neurofibromatosis Therapeutics Market

https://www.futuremarketinsights.com/reports/neurofibromatosis-therapeutics-market

License

Buy Now

Summary ToC Infographics Companies

Infographics

Neurofibromatosis Therapeutics Market Industry Value Analysis

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Neurofibromatosis Therapeutics Market

Infographics

Similar Industry Reports